DEMOCRITUS UNIVERSITY OF THRACE
🇬🇷Greece
Clinical Trials
62
Active:2
Completed:45
Trial Phases
2 Phases
Phase 3:1
Not Applicable:20
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials
Not Applicable
20 (95.2%)Phase 3
1 (4.8%)In Vitro and in Vivo Evaluation of the Anti-Inflammatory and Antithrombotic Synergy of Vitamin C and Bioflavonoids in Healthy Subjects
Not Applicable
Completed
- Conditions
- Cardio-protection
- First Posted Date
- 2025-07-11
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Democritus University of Thrace
- Target Recruit Count
- 20
- Registration Number
- NCT07061431
- Locations
- 🇬🇷
School of Chemistry, Faculty of Sciences, Democritus University of Thrace, Kavála, Kavala, Greece
The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration
Not yet recruiting
- Conditions
- AMD - Age-Related Macular Degeneration
- First Posted Date
- 2025-07-11
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- Democritus University of Thrace
- Target Recruit Count
- 70
- Registration Number
- NCT07060196
- Locations
- 🇬🇷
University Hospital of Alexandroupolis, Alexandroupolis, Greece
Effects of an Acute Dose of Caffeine on the Performance of CrossFit Athletes
Not Applicable
Completed
- Conditions
- Healthy, Young AdultsAthletic Performance
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Democritus University of Thrace
- Target Recruit Count
- 12
- Registration Number
- NCT06891469
- Locations
- 🇬🇷
Stefanos Karalis Indoors Facilities, Athens, Byron, Greece
The Postsurgical Pain in Elderly Patients Suffering From Undernourishment
Completed
- Conditions
- UndernutritionPain
- First Posted Date
- 2025-01-31
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Democritus University of Thrace
- Target Recruit Count
- 81
- Registration Number
- NCT06802575
- Locations
- 🇬🇷
General Hospital of Drama, Dráma, Greece
PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS
Phase 3
Recruiting
- Conditions
- Diuretics Drug ReactionsHeart Failure; With DecompensationAlbumin; Double
- Interventions
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Democritus University of Thrace
- Target Recruit Count
- 250
- Registration Number
- NCT06630923
- Locations
- 🇬🇷
DUThrace Cardiology Department, Alexandroupolis, Evros, Greece
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
News
No news found